Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer

The present study was conducted to evaluate the efficacy and safety of a combination regimen of capecitabine plus irinotecan in patients with advanced gastric cancer. Patients with previously untreated metastatic or recurrent, measurable gastric cancer received oral capecitabine 1000 mg m(−2) twice...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, J H, Kim, J G, Jeon, S B, Chae, Y S, Kim, D H, Sohn, S K, Lee, K B, Choi, Y J, Shin, H J, Chung, J S, Cho, G J, Jung, H Y, Yu, W
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361294/
https://www.ncbi.nlm.nih.gov/pubmed/16641916
http://dx.doi.org/10.1038/sj.bjc.6603093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361294/
https://www.ncbi.nlm.nih.gov/pubmed/16641916
http://dx.doi.org/10.1038/sj.bjc.6603093

Ejemplares similares